Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
Multiple Sclerosis and Related Disorders|May 31, 2020
'Is RLS a harbinger and consequence of MS?: Striking results of the 'RELOMS-T' study'Serhan Sevim, Meltem Demirkıran, Murat Terzi, et al.
Multiple Sclerosis and Related Disorders|February 6, 2023
Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activityTim Spelman, Dana Horakova, Serkan Ozakbas, et al.
Multiple Sclerosis and Related Disorders|November 29, 2017
Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimodYara Dadalti Fragoso, Tim Spelman, Cavit Boz, et al.
Multiple Sclerosis and Related Disorders|July 17, 2023
Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical settingBengü Altunan, Aysun Ünal, Hüsnü Efendi, et al.
Journal of the Neurological Sciences|August 15, 2018
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapyIlya Kister, Tim Spelman, Francesco Patti, et al.
Arquivos De Neuro-Psiquiatria|February 23, 2022
Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depressionSerhan Sevim, Meltem Demirkiran, Murat Terzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 23, 2023
The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosisCavit Boz, Serkan Ozakbas, Murat Terzi, et al.
Multiple Sclerosis and Related Disorders|February 9, 2024
The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosisEsra Taşkıran, Murat Terzi, Elif Merve Helvacı, et al.
The Neurologist|October 16, 2015
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory FeaturesAyse Altintas, Rana Karabudak, Belgin P Balci, et al.
Multiple Sclerosis and Related Disorders|September 2, 2019
Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosisCavit Boz, Murat Terzi, Bilge Özer, et al.
Pageof 15